(Q44345244)

2 December 2017

Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice (English)

1 reference

2 December 2017

0 references

0 references

2

1 reference

2 December 2017

Soichiro Ide

1

1 reference

2 December 2017

Masamichi Satoh

3

1 reference

2 December 2017

George R Uhl

4

1 reference

2 December 2017

Ichiro Sora

5

1 reference

2 December 2017

Kazutaka Ikeda

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

2 December 2017

Neuropsychopharmacology

1 reference

2 December 2017

29

1 reference

2 December 2017

9

1 reference

2 December 2017

1656-1663

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300463

2 December 2017

0 references

cites work

Differential opioid agonist regulation of the mouse mu opioid receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Intravenous buprenorphine self-administration by detoxified heroin abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Agonist and antagonist properties of buprenorphine, a new antinociceptive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Blockade of morphine reward through the activation of kappa-opioid receptors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Preferential stimulation of D1 or D2 receptors disrupts food-rewarded operant responding in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Unique behavioural phenotypes of recombinant-inbred CXBK mice: partial deficiency of sensitivity to mu- and kappa-agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Buprenorphine exerts its antinociceptive activity via mu 1-opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Pharmacological study of dihydroetorphine in cloned mu-, delta- and kappa-opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Opioids: first lessons from knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Buprenorphine is a potent kappa-opioid receptor antagonist in pigeons and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Progressive ratio performance maintained by buprenorphine, heroin and methadone in Macaque monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: identification of non-peptide delta-inverse agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

The mu-opioid receptor is necessary for [D-Pen2,D-Pen5]enkephalin-induced analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

7 January 2021

The untranslated region of (mu)-opioid receptor mRNA contributes to reduced opioid sensitivity in CXBK mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

7 January 2021

Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

7 January 2021

Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300463

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300463

1 reference

2 December 2017

1 reference